Update on the Development of Anti-Viral Agents Against Hepatitis C
Open Access
- 1 September 2013
- journal article
- review article
- Published by Xia & He Publishing in Journal of Clinical and Translational Hepatology
- Vol. 1 (1), 9-21
- https://doi.org/10.14218/JCTH.2013.007XX
Abstract
JCTH,Journal of Clinical and Translational HepatologyKeywords
This publication has 97 references indexed in Scilit:
- Unbiased probing of the entire hepatitis C virus life cycle identifies clinical compounds that target multiple aspects of the infectionProceedings of the National Academy of Sciences of the United States of America, 2009
- Telaprevir with Peginterferon and Ribavirin for Chronic HCV Genotype 1 InfectionThe New England Journal of Medicine, 2009
- Hepatitis C virus NS2 is a protease stimulated by cofactor domains in NS3Proceedings of the National Academy of Sciences of the United States of America, 2009
- Structure and function of HCV IRES domainsVirus Research, 2009
- Treatment failure in hepatitis C: Mechanisms of non-responseJournal of Hepatology, 2009
- The Domains of Polypyrimidine Tract Binding Protein Have Distinct RNA Structural PreferencesBiochemistry, 2009
- Human occludin is a hepatitis C virus entry factor required for infection of mouse cellsNature, 2009
- Structural determinants for membrane association and dynamic organization of the hepatitis C virus NS3-4A complexProceedings of the National Academy of Sciences of the United States of America, 2008
- Claudin-1 is a hepatitis C virus co-receptor required for a late step in entryNature, 2007
- Production of infectious hepatitis C virus in tissue culture from a cloned viral genomeNature Medicine, 2005